When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Toxic thyroid adenoma

最后审阅: 21 Mar 2026
最后更新: 01 Oct 2024

小结

定义

病史和体格检查

关键诊断因素

  • palpable thyroid nodule
  • younger age
完整详情

其他诊断因素

  • hyperphagia
  • weight loss
  • sweating/heat intolerance
  • nervousness
  • palpitations
  • oligomenorrhea
  • hyperdefecation
  • dyspnea
  • stare or lid lag
  • tachycardia
  • tremor
  • warm moist skin
  • muscle weakness
  • hoarseness
  • dysphagia
  • choking
  • mood change
完整详情

危险因素

  • young adult age
  • iodine deficiency
  • head and neck irradiation
  • family history of thyroid nodules
  • female sex
完整详情

诊断性检查

首要检查

  • thyroid stimulating hormone (TSH)
完整详情

需考虑的检查

  • free thyroxine (T4; or total T4 with a measure of binding)
  • total T3 with a measure of binding (or free T3)
  • thyroid scan and uptake
  • thyroid ultrasound
  • metabolic panel
  • CBC
  • TSH receptor antibodies
  • thyroid peroxidase antibodies
  • ECG
  • CT neck (noncontrast)
完整详情

治疗流程

持续性治疗

nonpregnant nonlactating adults without mass effect

nonpregnant nonlactating adults with mass effect

pregnant or lactating

撰稿人

作者

Elizabeth N. Pearce, MD

Professor of Medicine

Boston University Medical Center

Boston

MA

利益声明

ENP is a member of the Management Council of the Iodine Global Network. She was the 2018-2019 President of the American Thyroid Association (ATA) and served on its board and executive committee until 2020. She is a current member of the ATA's thyroid in pregnancy guidelines writing task force. She is currently a Deputy Editor at the Journal of Clinical Endocrinology and Metabolism and has previously served as an Associated Editor for the journals Thyroid, Endocrine Practice, and Clinical Thyroidology. She is an author of a number of references cited in this topic.

鸣谢

Dr Elizabeth N. Pearce would like to gratefully acknowledge Dr Sheila Feit, the previous contributor to this topic.

同行评议者

John C. Morris, MD

Professor of Medicine

Mayo Clinic

Rochester

MN

利益声明

JCM declares that he has no competing interests.

Petros Perros, BSc, MBBS, MD, FRCP

Consultant Endocrinologist

Freeman Hospital

Newcastle-Upon-Tyne

UK

利益声明

PP declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.全文  摘要

Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.全文  摘要

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Toxic thyroid adenoma images
  • 鉴别诊断

    • Graves disease
    • Toxic multinodular goiter
    • Thyrotoxic phase of painless lymphocytic thyroiditis
    更多 鉴别诊断
  • 指南

    • Thyroid nodule algorithmic tool white paper
    • Practice parameter for treatment of benign and malignant thyroid disease with I-131 sodium iodide
    更多 指南
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明